USPTO trademark

RETHINK PLGG

RegisteredUSPTOWord markClass 35Class 41Class 44

"RETHINK PLGG" is a word mark owned by Day One Biopharmaceuticals, Inc., filed at the USPTO on December 19, 2022. It is registered and covers classes 35, 41 and 44.

Official USPTO record
RETHINK PLGG trademark as filed
As filed with the USPTO
Status
Registered
Since September 3, 2024
Filed
December 19, 2022
Registered
September 3, 2024
Expires
Not recorded
Application no.
97724047
Registration no.
7496917
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns RETHINK PLGG

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services RETHINK PLGG is filed for, grouped by Nice class.

  • Promoting public awareness of tumors and cancer; promoting public awareness of pediatric low-grade glioma

  • Educational services, namely, providing online non-downloadable videos in the field of treatment and diagnosis of tumors and cancer; educational services, namely, providing online non-downloadable videos in the field of treatment and diagnosis of pediatric low-grade glioma; educational services, namely, providing online non-downloadable videos for healthcare service providers, caregivers, and patients in the field of tumors and cancer; educational services, namely, providing online non-downloadable videos for healthcare service providers, caregivers, and patients in the field of pediatric low-grade glioma

  • Providing a website featuring health information in the field of tumors and cancer; providing a website featuring health information in the field of pediatric low-grade glioma; providing medical information regarding the treatment and diagnosis of tumors and cancer; providing medical information regarding the treatment and diagnosis of pediatric low-grade glioma; providing medical information and health advice for healthcare service providers, caregivers, and patients in connection with tumors and cancer; providing medical information and health advice for healthcare service providers, caregivers, and patients in connection with pediatric low-grade glioma

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Applicant/correspondence changes (non-responsive) entered
  5. Teas change of owner address received
  6. Teas change of correspondence received
  7. Attorney/dom.rep.revoked and/or appointed
  8. Teas revoke/app/change addr of atty/dom rep received
  9. Applicant/correspondence changes (non-responsive) entered
  10. Teas change of owner address received

10 earlier steps on the official record.

FAQ

About RETHINK PLGG

Who owns the trademark "RETHINK PLGG"?

The USPTO trademark "RETHINK PLGG" (application 97724047) is owned by Day One Biopharmaceuticals, Inc.

What is the status of "RETHINK PLGG"?

Its status at the USPTO is: registered.

When was "RETHINK PLGG" registered?

It was registered on September 3, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RETHINK PLGG and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2b37-8151-7697-b66c-31db25c45f64
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b37-8151-7697-b66c-31db25c45f64",
  "object": "trademark",
  "mark_text": "RETHINK PLGG",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97724047",
  "filing_date": "2022-12-19",
  "nice_classes": [
    35,
    41,
    44
  ],
  "owners": [
    {
      "name": "Day One Biopharmaceuticals, Inc.",
      "entity_id": "ent_019eb70d-dcad-750c-ae09-14c47ca4aad6"
    }
  ]
}